CTLA4 and temporal arteritis: Furthermore, a recent multicenter clinical study of patients with ICI‐induced GCA revealed that individuals receiving dual therapy with CTLA‐4 and PD‐1/L1 blockers more frequently exhibited cranial involvement, including permanent visual loss, compared with those treated with PD‐1 blockers alone, highlighting the significant role of CTLA‐4 signaling.41